Shanghai General Healthy Information and Technology Co., Ltd. (SHA:605186)
25.62
-0.39 (-1.50%)
Sep 4, 2026, 3:00 PM CST
SHA:605186 Revenue
Shanghai General Healthy Information and Technology had revenue of 108.78M CNY in the quarter ending June 30, 2026, with 33.31% growth. This brings the company's revenue in the last twelve months to 371.61M, up 12.10% year-over-year. In the year 2025, Shanghai General Healthy Information and Technology had annual revenue of 345.49M with 8.52% growth.
Revenue (ttm)
371.61M
Revenue Growth
+12.10%
P/S Ratio
9.38
Revenue / Employee
1.10M
Employees
337
Market Cap
3.48B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 345.49M | 27.14M | 8.52% |
| Dec 31, 2024 | 318.35M | 10.79M | 3.51% |
| Dec 31, 2023 | 307.56M | -14.80M | -4.59% |
| Dec 31, 2022 | 322.36M | -167.40M | -34.18% |
| Dec 31, 2021 | 489.76M | 202.95M | 70.76% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Guangdong Biolight Meditech | 1.09B |
| Zhejiang Orient Gene Biotech | 1.01B |
| Shanghai Aohua Photoelectricity Endoscope | 793.05M |
| Ningbo David Medical Device | 584.68M |
| Chison Medical Technologies | 441.10M |
| Medprin Regenerative Medical Technologies | 400.85M |
| Tellgen | 392.11M |
| CareRay Digital Medical Technology | 319.79M |